Variant report

Variant	nsv7689
Chromosome Location	chr11:16945953-16990852
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:108)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:108 , 50 per page) page: 1 2 3

No.	Distal block	Cell Line	Cell type
1	chr11:16841442..16842549-chr11:16957140..16957982,3	MCF-7	breast:
2	chr11:16977925..16978855-chr11:17007771..17009390,6	MCF-7	breast:
3	chr11:16967067..16971256-chr11:17030990..17035290,3	MCF-7	breast:
4	chr11:16968895..16971125-chr11:16971193..16973951,2	MCF-7	breast:
5	chr11:16980702..16983607-chr11:16983722..16985302,2	MCF-7	breast:
6	chr11:16977974..16978869-chr11:17010653..17011499,5	MCF-7	breast:
7	chr11:16978286..16981863-chr11:16983113..16986432,3	K562	blood:
8	chr11:16970516..16973330-chr11:16980967..16983342,2	K562	blood:
9	chr11:16964680..16966696-chr11:17223543..17226223,2	K562	blood:
10	chr11:16958660..16960356-chr11:17034673..17037348,2	MCF-7	breast:
11	chr11:16975727..16978192-chr11:16983279..16985913,2	MCF-7	breast:
12	chr11:16817999..16818627-chr11:16977958..16978485,2	MCF-7	breast:
13	chr11:16976871..16981000-chr11:17000472..17004649,3	MCF-7	breast:
14	chr11:16960396..16961023-chr11:16977926..16978498,2	MCF-7	breast:
15	chr11:16957493..16958020-chr11:17084682..17085371,2	MCF-7	breast:
16	chr11:16978219..16978915-chr11:17003760..17004705,2	MCF-7	breast:
17	chr11:16945639..16949520-chr11:16949584..16951727,4	MCF-7	breast:
18	chr11:16983037..16985172-chr11:16987078..16988742,2	MCF-7	breast:
19	chr11:16970711..16972970-chr11:16979069..16980668,2	K562	blood:
20	chr11:16759050..16760785-chr11:16980346..16982493,2	MCF-7	breast:
21	chr11:16990664..16992333-chr11:17006870..17009444,2	MCF-7	breast:
22	chr11:16964831..16967704-chr11:17003456..17005667,3	MCF-7	breast:
23	chr11:16939336..16941584-chr11:16944195..16948360,3	K562	blood:
24	chr11:16970516..16973330-chr11:16980967..16983342,2	K562	blood:
25	chr11:16978219..16978915-chr11:17003760..17004740,5	MCF-7	breast:
26	chr11:16983360..16985149-chr11:16987896..16990823,2	MCF-7	breast:
27	chr11:16976889..16978865-chr11:17008807..17011495,3	MCF-7	breast:
28	chr11:16947021..16948883-chr11:16954083..16956444,2	MCF-7	breast:
29	chr11:16943395..16946127-chr11:17034525..17036594,2	MCF-7	breast:
30	chr11:16980630..16982721-chr11:16985840..16988789,2	MCF-7	breast:
31	chr11:16964786..16967278-chr11:17097701..17099314,2	MCF-7	breast:
32	chr11:16946793..16948459-chr14:74981920..74983438,2	MCF-7	breast:
33	chr11:16978078..16978699-chr11:17032228..17032731,2	MCF-7	breast:
34	chr11:16966796..16968842-chr11:17094768..17096924,2	MCF-7	breast:
35	chr11:16806277..16809061-chr11:16956552..16959542,2	MCF-7	breast:
36	chr11:16960761..16963314-chr11:17099363..17101117,2	MCF-7	breast:
37	chr11:16947090..16949629-chr11:17095736..17097514,2	MCF-7	breast:
38	chr11:16902742..16904813-chr11:16945225..16947664,2	MCF-7	breast:
39	chr11:16966859..16968159-chr11:17084631..17085602,16	MCF-7	breast:
40	chr11:16948844..16950381-chr11:16953392..16956002,2	K562	blood:
41	chr11:16980702..16983607-chr11:16983722..16985302,2	MCF-7	breast:
42	chr11:16970711..16972970-chr11:16979069..16980668,2	K562	blood:
43	chr11:16988453..16990354-chr11:17039773..17042138,2	MCF-7	breast:
44	chr11:16976807..16979737-chr11:16986276..16990868,5	MCF-7	breast:
45	chr11:16971884..16974479-chr11:17097308..17099759,2	K562	blood:
46	chr11:16977908..16978974-chr11:17010587..17011618,48	MCF-7	breast:
47	chr11:16978004..16978751-chr11:20053101..20054014,2	MCF-7	breast:
48	chr11:16809904..16810462-chr11:16957366..16958037,2	MCF-7	breast:
49	chr11:16978198..16978723-chr11:76483683..76484202,2	MCF-7	breast:
50	chr11:16978066..16978747-chr11:17007921..17008692,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000110696	chromatin interactions
ENSG00000110693	chromatin interactions
ENSG00000201403	chromatin interactions
ENSG00000110700	chromatin interactions
ENSG00000272034	chromatin interactions
ENSG00000184669	chromatin interactions
ENSG00000221322	chromatin interactions
ENSG00000166689	chromatin interactions

Extended variants
information (count: 1608 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:1608 , 50 per page) page: 1 2 3 4 5 6 7 ... 33

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs186651607	chr11:16946069-16946070	Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs541324776	chr11:16946088-16946089	Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs4757445	chr11:16946101-16946102	Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs370549326	chr11:16946117-16946118	Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs11024078	chr11:16946126-16946127	Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs539308598	chr11:16946174-16946175	Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs190018750	chr11:16946180-16946181	Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs548798540	chr11:16946198-16946199	Bivalent Enhancer Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs542756500	chr11:16946241-16946242	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs567114203	chr11:16946245-16946246	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs181153901	chr11:16946264-16946265	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs185112882	chr11:16946302-16946303	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs564707105	chr11:16946303-16946304	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs532290121	chr11:16946323-16946324	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs550444212	chr11:16946343-16946344	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs189531298	chr11:16946355-16946356	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs181947755	chr11:16946369-16946370	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs375487215	chr11:16946394-16946395	Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs12292080	chr11:16946400-16946401	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers Flanking Active TSS Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs77327179	chr11:16946460-16946461	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs535093170	chr11:16946468-16946469	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs551551485	chr11:16946484-16946485	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs547234348	chr11:16946496-16946497	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs571857258	chr11:16946572-16946573	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs10766359	chr11:16946604-16946605	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs576825968	chr11:16946649-16946650	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs187239472	chr11:16946699-16946700	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
28	rs528225430	chr11:16946722-16946723	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs192247849	chr11:16946736-16946737	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Bivalent Enhancer Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs191916081	chr11:16946808-16946809	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs371494586	chr11:16946814-16946815	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs183782529	chr11:16946921-16946922	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs117641986	chr11:16946942-16946943	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs371535350	chr11:16946994-16946995	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs145635183	chr11:16947015-16947016	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs564771958	chr11:16947066-16947067	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs10832700	chr11:16947094-16947095	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs544540085	chr11:16947125-16947126	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs562650487	chr11:16947182-16947183	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs4756874	chr11:16947185-16947186	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs71484744	chr11:16947219-16947220	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs561302069	chr11:16947277-16947278	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs528634140	chr11:16947279-16947280	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs546500648	chr11:16947310-16947311	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs571918401	chr11:16947315-16947316	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs539451114	chr11:16947335-16947336	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs551111910	chr11:16947380-16947381	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs571484577	chr11:16947389-16947390	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs536921366	chr11:16947394-16947395	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs574470656	chr11:16947409-16947410	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Cancer	21183584	CNVD
Gastric adenocarcinoma	19115996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
small cell lung cancer	20016488	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Multiple myeloma	16461302	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21858162	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Neuroblastoma	21899760	CNVD
Lung adenocarcinoma	17086460	CNVD
Urothelial cell carcinoma	18451213	CNVD
Lung cancer	17086460	CNVD
Uterine serous papillary cancer	19536090	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Medulloblastoma	16783165	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:1028 , 50 per page) page: 1 2 3 4 5 6 7 ... 21

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:16943400-16946400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr11:16943800-16946200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
3	chr11:16944000-16946000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
4	chr11:16944000-16946000	Enhancers	Left Ventricle	heart
5	chr11:16944000-16946000	Enhancers	Sigmoid Colon	Sigmoid Colon
6	chr11:16944400-16946000	Enhancers	Breast Myoepithelial Primary Cells	Breast
7	chr11:16944400-16946000	Enhancers	Gastric	stomach
8	chr11:16944400-16946400	Enhancers	Pancreas	Pancrea
9	chr11:16944400-16946600	Enhancers	Lung	lung
10	chr11:16944600-16946400	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr11:16944800-16946000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
12	chr11:16944800-16946400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr11:16944800-16946400	Flanking Active TSS	Rectal Mucosa Donor 31	rectum
14	chr11:16945000-16946200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
15	chr11:16945000-16946200	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr11:16945000-16947200	Bivalent Enhancer	Fetal Lung	lung
17	chr11:16945000-16947600	Active TSS	Fetal Heart	heart
18	chr11:16945200-16946000	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
19	chr11:16945200-16946200	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
20	chr11:16945200-16946200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
21	chr11:16945200-16946400	Enhancers	Primary B cells from peripheral blood	blood
22	chr11:16945400-16946000	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
23	chr11:16945400-16946000	Flanking Active TSS	Ovary	ovary
24	chr11:16945400-16946200	Flanking Active TSS	Right Ventricle	heart
25	chr11:16945400-16946400	Flanking Active TSS	Hela-S3	cervix
26	chr11:16945400-16947600	Active TSS	Right Atrium	heart
27	chr11:16945600-16946200	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
28	chr11:16945600-16946200	Flanking Active TSS	Esophagus	oesophagus
29	chr11:16945600-16946200	Enhancers	HepG2	liver
30	chr11:16945600-16946400	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
31	chr11:16945600-16946400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
32	chr11:16945600-16946400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
33	chr11:16945600-16946400	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
34	chr11:16945600-16946400	Bivalent Enhancer	Fetal Muscle Leg	muscle
35	chr11:16945600-16946400	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
36	chr11:16945600-16946600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr11:16945600-16946800	Bivalent Enhancer	Fetal Brain Male	brain
38	chr11:16945600-16947600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
39	chr11:16945600-16947600	Flanking Active TSS	HMEC	breast
40	chr11:16945600-16947800	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
41	chr11:16945600-16947800	Active TSS	Pancreatic Islets	Pancreatic Islet
42	chr11:16945800-16946000	Flanking Active TSS	Duodenum Mucosa	Duodenum
43	chr11:16945800-16946000	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
44	chr11:16945800-16946000	Bivalent Enhancer	Placenta	Placenta
45	chr11:16945800-16946000	Bivalent/Poised TSS	Fetal Stomach	stomach
46	chr11:16945800-16946000	Flanking Active TSS	Placenta Amnion	Placenta Amnion
47	chr11:16945800-16946000	Bivalent Enhancer	Thymus	Thymus
48	chr11:16945800-16946200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
49	chr11:16945800-16946200	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
50	chr11:16945800-16946200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links